Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Surrey
Clinical trial register · Canada

Clinical Trials in Surrey, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6553 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:20 UTC
6553
Studies in scope
all four open statuses
3487
Recruiting now
open to new participants
880
Lead sponsors
across recruiting studies
Top sites
Toronto 2818 Montreal 1913 Vancouver 1187 Calgary 1068 Edmonton 1018
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Salem Anaesthesia Pain Clinic12 AstraZeneca7 University of British Columbia6 British Columbia Cancer Agency6 AbbVie5 Oruka Therapeutics, Inc.5 Canadian Cancer Trials Group5 Sanofi4 Novo Nordisk A/S4 Merck Sharp & Dohme LLC4 Janssen Research & Development, LLC4 Eli Lilly and Company4 National Cancer Institute (NCI)4 Amgen3 Colorado Prevention Center3 Pfizer3 Incyte Corporation3 Boehringer Ingelheim3 Novartis Pharmaceuticals3 Sun Pharmaceutical Industries, Inc.2 Inmagene LLC2 University Health Network, Toronto2 Alumis Inc2 Todd C. Lee MD MPH FIDSA2 Hoffmann-La Roche2 Show all 62
Site location
Toronto2818 Montreal1913 Vancouver1187 Calgary1068 Edmonton1018 Ottawa884 London878 Hamilton811 Québec682 Halifax535 Winnipeg454 Sherbrooke264 Kingston254 Kelowna176 Brampton143 Surrey138 Victoria129 St. John's126 Barrie125 Saskatoon125 Chicoutimi100 Moncton92 Mississauga89 Greater Sudbury83 Regina82 Show all 248
All 248 locations
Target enrolment
to

Trials with a site in Surrey

138 of 6553 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Not yet open
University of British Columbia
Observational
102
Calgary, Cranbrook, Kelowna, New Westminster, Surrey, Vancouver, Winnipeg, London
2027-01
Not yet open
Guliz Ozgun
Phase 3
224
Abbotsford British Columbia, Kelowna, Surrey, Vancouver, Victoria
2026-11
Recruiting
Spyre Therapeutics, Inc.
Phase 2
150
Edmonton, Surrey, Winnipeg, Barrie, Markham, Richmond Hill, Québec, Saskatoon
2026-09
Recruiting
AstraZeneca
Phase 3
500
Calgary, Surrey, Vancouver, Guelph, Hamilton, Stouffville, Toronto, Joliette
2026-08-24
Recruiting
Oruka Therapeutics, Inc.
Phase 2
200
Surrey, Barrie, London, Peterborough, Waterloo
2026-08-21
Recruiting
AstraZeneca
Phase 3
2,500
Calgary, New Westminster, Surrey, Victoria, Moncton, Truro, Brampton, Guelph
2026-08-19
Recruiting
AstraZeneca
Phase 3
600
Surrey, Vancouver, Brampton, North York, Sarnia, Scarborough Village, Toronto, Saint-Charles-Borromée
2026-07-08
Active, closed
Boehringer Ingelheim
Phase 2
344
Surrey, Victoria, Guelph, Hamilton, London, Stouffville, Toronto, Chicoutimi
2026-06-30
Recruiting
argenx
Phase 3
230
Montreal, Surrey
2026-06-10
Recruiting
Pfizer
Phase 3
954
Surrey, Moncton, Hamilton, Toronto
2026-06-10
By invitation
Inmagene LLC
Phase 2
400
Surrey, Vancouver, Greater Sudbury, Mississauga, North Bay, Montreal, Saskatoon
2026-06-05
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Calgary, Kelowna, Surrey, Victoria, Moncton, Halifax, Sydney, Brampton
2026-05-21
Recruiting
Novo Nordisk A/S
Phase 3
400
Surrey, Niagara Falls, Lévis, Montreal, Québec, Sherbrooke
2026-04-20
Active, closed
Oruka Therapeutics, Inc.
Phase 2
160
Edmonton, Surrey, Barrie, London, North Bay, Peterborough, Toronto, Waterloo
2026-03-19
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Calgary, Surrey, Brampton, Hamilton, Sarnia, Trois-Rivières, Québec
2026-03-16
Recruiting
Novo Nordisk A/S
Phase 3
1,150
Calgary, Surrey, Moncton, Halifax, London
2026-02-24
Recruiting
Oruka Therapeutics, Inc.
Phase 2
240
Edmonton, Surrey, Fredericton, Ajax, London, Markham, Peterborough, Toronto
2026-02-23
Not yet open
Legion Veterans Village Research Foundation
Phase 4
30
Surrey
2026-01
Recruiting
Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers
NCT06918951Oligoprogression, Oligometastatic Disease, OligoProgressive Metastatic Disease
British Columbia Cancer Agency
Not applicable
194
Surrey
2025-12-04
Active, closed
Oruka Therapeutics, Inc.
Phase 2
160
Surrey, Fredericton, Ajax, Markham, Peterborough, Montreal, Québec
2025-12-03
Active, closed
Kymera Therapeutics, Inc.
Phase 2
200
Calgary, Edmonton, Kelowna, Surrey, Markham, Ottawa, Richmond Hill, Toronto
2025-11-24
Recruiting
UCB Biopharma SRL
Phase 3
320
Barrie, Calgary, Fredericton, London, Québec, Red Deer, Surrey
2025-11-14
Recruiting
Eli Lilly and Company
Phase 3
1,630
Calgary, Hamilton, Montreal, Sherbrooke, Surrey, Toronto
2025-10-22
Recruiting
University of British Columbia
Not applicable
74
Kelowna, Surrey, Vancouver
2025-10-21
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Calgary, Edmonton, Kelowna, Nanaimo, Surrey, Winnipeg, St. John's, Ajax
2025-09-22
Recruiting
LEO Pharma
Phase 2
135
Calgary, Edmonton, Surrey, Winnipeg, Fredericton, Hamilton, Markham, Waterloo
2025-09-11
Recruiting
British Columbia Cancer Agency
Phase 2
100
Surrey, Victoria
2025-09-04
Recruiting
Sanofi
Phase 2
30
Calgary, Surrey, Sherbrooke
2025-09-02
Recruiting
Amgen
Phase 3
11,000
Calgary, Edmonton, New Westminster, Surrey, Vancouver, Victoria, Brampton, Burlington
2025-08-22
Recruiting
Sun Pharmaceutical Industries, Inc.
Phase 3
355
Calgary, Edmonton, Red Deer, Kelowna, Surrey, Markham, Newmarket, Toronto
2025-08-05
Recruiting
St. Joseph's Healthcare Hamilton
Phase 3
846
Surrey, Brockville, Hamilton, Toronto
2025-07-29
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Calgary, Red Deer, Kelowna, New Westminster, North Vancouver, Penticton, Surrey, Moncton
2025-07-22
Active, closed
Oruka Therapeutics, Inc.
Phase 2
80
Edmonton, Surrey, Hamilton, London, Markham, Peterborough, Toronto, Waterloo
2025-07-18
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Paraplatin
Merck Sharp & Dohme LLC
Phase 3
2,400
Surrey, Vancouver, St. John's, Barrie, Greater Sudbury, Oshawa, Ottawa, Sault Ste. Marie
2025-06-30
Recruiting
Inmagene LLC
Phase 2
405
Surrey, Vancouver, Greater Sudbury, Mississauga, North Bay, Montreal, Saskatoon
2025-06-17
Active, closed
Incyte Corporation
Phase 3
159
Calgary, Edmonton, Surrey, Vancouver, Winnipeg, Hamilton, Toronto, Montreal
2025-06-17
Active, closed
AstraZeneca
Phase 3
3,103
Surrey, Vancouver, Cambridge, Courtice, Guelph, Hamilton, Mississauga, North York
2025-05-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Surrey, Winnipeg, St. John's, Barrie, London, Sault Ste. Marie, Toronto, Windsor
2025-05-22
Active, closed
Eli Lilly and Company
Phase 3
465
Montreal, Ottawa, Sherbrooke, Surrey, Sydney
2025-05-12
By invitation
Dr George Medvedev
Phase 3
102
New Westminster, Surrey
2025-05-05
By invitation
University of British Columbia
Not applicable
60
Surrey, Vancouver
2025-04-20
Recruiting
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
NCT05784428Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy, Quality of Life
Robert Olson
Not applicable
598
Kelowna, Prince George, Surrey, Vancouver, Victoria, Greater Sudbury, Toronto
2025-04-16
Recruiting
University Health Network, Toronto
Observational
3,000
Surrey, Moncton, North York, Saint Catharines, Toronto, Montreal
2025-04-14
Recruiting
Canadian Cancer Trials Group
Phase 2
128
Abbotsford British Columbia, Surrey, Vancouver, Hamilton, London, Newmarket, Ottawa, Toronto
2025-04-07
Recruiting
Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy
NCT05786599Chemotherapy-induced Peripheral Neuropathy
DrugsMethadone·Duloxetine
University of British Columbia
Phase 2/3
50
Nanaimo, Surrey, Vancouver, Victoria
2025-03-21
Active, closed
Amgen
Phase 3
1,105
Surrey, Winnipeg, Halifax, Brampton, Concord, Hamilton, London, Nepean
2025-03-17
Active, closed
Amgen
Phase 3
3,853
Surrey, Hamilton, North York, Oshawa, Scarborough Village, Thunder Bay, Toronto, Chicoutimi
2025-03-12
Recruiting
Pfizer
Phase 3
723
Red Deer, Kelowna, Surrey, Halifax, Brampton, Sarnia, Lévis
2025-03-11
Recruiting
AstraZeneca
Phase 3
5,000
Edmonton, Surrey, Vancouver, Winnipeg, Saint John, Halifax, Etobicoke, London
2025-03-03
Active, closed
Sanofi
Phase 2
84
Surrey, Vancouver
2025-02-28
Active, closed
Novartis Pharmaceuticals
Phase 3
588
Surrey, St. John's, Hamilton, Richmond Hill, Québec, Saint-Jérôme
2025-01-31
Recruiting
Modifying PEST for Psoriatic Arthritis Screening
NCT06382051Plaque Psoriasis, Psoriatic Arthritis
Novartis Pharmaceuticals
Not applicable
502
Calgary, Edmonton, Kelowna, Surrey, Winnipeg, Fredericton, Barrie, Greater Sudbury
2025-01-23
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Edmonton, Red Deer, Surrey, Ajax, Barrie, Coburg, Guelph, Hamilton
2025-01-08
Not yet open
Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy
NCT06602661Lung, Lung Adenocarcinoma, Lung Adenosquamous Carcinoma, Lung Cancer, Non-Small Cell
Surrey Thoracic Surgery Group
Phase 1
65
Surrey
2025-01-01
Recruiting
Cytokinetics
Phase 3
1,800
Edmonton, Kelowna, Surrey, Vancouver, Victoria, Winnipeg, Kingston, London
2024-12-19
Recruiting
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
NCT06637332Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia, S. Aureus Bacteremia, S. Aureus Bloodstream Infection
DrugsDaptomycin·Vancomycin
Todd C. Lee MD MPH FIDSA
Phase 4
300
Edmonton, Surrey, St. John's, Hamilton, Toronto, Montreal
2024-11-14
Active, closed
Stemline Therapeutics, Inc.
Phase 3
4,556
Surrey, Vancouver, Barrie, London, Toronto, Montreal, Saint-Charles-Borromée, Saint-Jérôme
2024-09-27
Active, closed
Takeda
Phase 3
2,099
Calgary, Edmonton, Red Deer, Surrey, Winnipeg, St. John's, Ajax, Barrie
2024-09-04
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Edmonton, Kamloops, Kelowna, Prince George, Surrey, Vancouver, Québec, Halifax
2024-08-30
Recruiting
Colorado Prevention Center
Phase 3
2,600
Calgary, Edmonton, North Vancouver, Surrey, Victoria, Winnipeg, Greater Sudbury, Kingston
2024-08-20
Active, closed
GlaxoSmithKline
Phase 3
10,212
Edmonton, New Westminster, Surrey, Vancouver, Victoria, Halifax, Truro, Greater Sudbury
2024-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Kelowna, Surrey, Victoria, Barrie, Hamilton, Montreal, Québec
2024-07-24
Recruiting
Colorado Prevention Center
Phase 3
1,500
Edmonton, Surrey, Greater Sudbury, London, North York, Toronto, Montreal, Sherbrooke
2024-07-09
Recruiting
University of British Columbia
Observational
4,400
Edmonton, Kelowna, Prince George, Surrey, Brandon, Winnipeg, Saint John, St. John's
2024-06-03
Recruiting
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
NCT04886284Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis, Staphylococcus Aureus Endocarditis
DrugErtapenem
Todd C. Lee MD MPH FIDSA
Phase 2
60
Calgary, Surrey, Hamilton, Ottawa, Saint Catharines, Laval, Montreal
2024-05-20
Active, closed
Sanofi
Phase 3
1,541
Calgary, Edmonton, Red Deer, Kelowna, Surrey, Winnipeg, Ajax, London
2024-05-08
Recruiting
A Platform Trial for Gram Negative Bloodstream Infections
NCT06537609Gram-negative Bacteremia
Sunnybrook Health Sciences Centre
Not applicable
2,500
Calgary, Edmonton, Surrey, Vancouver, Winnipeg, Fredericton, St. John's, Mississauga
2024-04-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Surrey, Newmarket, Toronto, Montreal, Québec, Rimouski
2024-04-14
Active, closed
Janssen Research & Development, LLC
Phase 3
731
Surrey, Winnipeg, London, Markham, Mississauga, Peterborough, Toronto, Windsor
2024-03-09
Active, closed
Incyte Corporation
Phase 3
617
Calgary, Edmonton, Surrey, Winnipeg, Fredericton, Barrie, Hamilton, London
2024-01-30
Active, closed
Janssen Research & Development, LLC
Phase 3
774
Surrey, St. John's, Ajax, Barrie, Hamilton, Richmond Hill, Waterloo, Windsor
2024-01-17
Recruiting
Colorado Prevention Center
Phase 3
5,200
Calgary, Edmonton, Kamloops, North Vancouver, Surrey, Vancouver, Winnipeg, Cambridge
2024-01-17
Active, closed
AbbVie
Phase 3
614
Calgary, Surrey, Winnipeg, Fredericton, Hamilton, Waterloo, Québec, Saint-Jérôme
2023-12-19
Active, closed
Incyte Corporation
Phase 3
467
Calgary, Surrey, Burlington, London, North YORK, Ottawa, Peterborough, Waterloo
2023-11-29
Active, closed
Nektar Therapeutics
Phase 2
396
Calgary, Edmonton, Kelowna, Surrey, Barrie, Markham, Peterborough, Richmond Hill
2023-11-15
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Calgary, Edmonton, Surrey, London, Newmarket, Toronto, Windsor, Montreal
2023-10-12
Recruiting
AbbVie
Phase 3
1,500
Calgary, Edmonton, Surrey, Winnipeg, Barrie, Greater Sudbury, Hamilton, Markham
2023-10-11
Active, closed
AstraZeneca
Phase 1/2
166
Surrey, Hamilton, Sarnia, Stouffville, Toronto, Sherbrooke
2023-09-29
Recruiting
University of Ottawa
Not applicable
100
Surrey, Toronto
2023-09-28
Recruiting
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
NCT05495906HPV, Human Papilloma Virus, Human Immunodeficiency Virus
DrugNonavalent HPV vaccine
University of British Columbia
Phase 4
275
Surrey, Vancouver, Winnipeg, Hamilton, Toronto, Montreal, Québec, Regina
2023-07-27
Recruiting
Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)
NCT05114096Preterm Birth, Premature Birth, Complication of Prematurity, Obstetric Labor, Premature
McMaster University
Phase 4
3,254
Calgary, Edmonton, New Westminster, Surrey, Vancouver, Victoria, Winnipeg, Fredericton
2023-07-20
Recruiting
Salem Anaesthesia Pain Clinic
Observational
350
Surrey
2023-07-01
Active, closed
AbbVie
Phase 3
1,328
Calgary, Edmonton, Red Deer, Surrey, Winnipeg, St. John's, Hamilton, London
2023-06-21
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NCT05440851Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High
University Health Network, Toronto
Not applicable
6,250
Calgary, Edmonton, Nanaimo, Surrey, Vancouver, Victoria, Winnipeg, Halifax
2023-04-30
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Calgery, Edmonton, New Westminster, Surrey, Victoria, Halifax, Brampton, Cambridge
2023-04-11
Active, closed
AbbVie
Phase 3
520
Calgary, Edmonton, Surrey, Vancouver, Hamilton, Kingston, Ottawa, Toronto
2023-03-15
Active, closed
Pfizer
Phase 3
624
Edmonton, Surrey, Moncton, Kitchener, Toronto, Saint-Jérôme
2023-03-03
Recruiting
Eli Lilly and Company
Phase 3
595
Calgary, Cobourg, Markham, Surrey, Toronto, Winnipeg
2023-02-27
Active, closed
Alumis Inc
Phase 2
165
Edmonton, Surrey, Winnipeg, London, Mississauga, North Bay, Oakville, Toronto
2023-01-17
Recruiting
Lemborexant vs Clonidine vs Sedatives to Treat Insomnia in Chronic Pain Patients
NCT05618002Chronic Insomnia, Chronic Pain, Restless Leg Syndrome (RLS), Substance Abuse
DrugsClonidine·Lemborexant
Salem Anaesthesia Pain Clinic
Observational
250
Surrey
2023-01-02
Active, closed
Ontario Clinical Oncology Group (OCOG)
Observational
526
Calgary, Edmonton, Abbotsford British Columbia, Prince George, Surrey, Vancouver, Victoria, Winnipeg
2022-11-23
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Edmonton, Sherwood Park, Surrey, Victoria, Moncton, Halifax, Hamilton
2022-11-01
Active, closed
Eli Lilly and Company
Phase 3
8,000
Calgary, London, Montreal, Québec, Surrey, Toronto
2022-10-04
Active, closed
Sanofi
Phase 2/3
1,856
Calgary, Edmonton, Red Deer, Surrey, Winnipeg, Ajax, Barrie, Hamilton
2022-08-22
Active, closed
British Columbia Cancer Agency
Phase 2
100
Abbotsford British Columbia, Kelowna, Prince George, Surrey, Vancouver, Victoria
2022-07-01
Active, closed
Celgene
Phase 3
939
Calgary, Edmonton, Surrey, Saint John, St. John's, Halifax, Ottawa, Québec
2022-06-23
Active, closed
Memorial University of Newfoundland
Phase 2/3
336
Calgary, Surrey, Carbonear
2022-04-01
Recruiting
University of Melbourne
Phase 4
8,000
Calgary, Edmonton, Richmond, Surrey, Vancouver, Winnipeg, St. John's, East York
2022-02-16
Recruiting
British Columbia Cancer Agency
Not applicable
168
Kelowna, Surrey, Vancouver, Victoria
2021-07-12
Active, closed
Canadian Cancer Trials Group
Phase 3
250
Kelowna, Surrey, Vancouver, Saint John, Halifax, Barrie, Brampton, Hamilton
2021-01-27
Active, closed
Hoffmann-La Roche
Phase 3
992
Calgary, Surrey, Barrie, Brampton, Ottawa, Toronto, Montreal, Québec
2020-10-09
Active, closed
PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA
NCT04015622Metastatic Castration-Resistant Prostate Cancer (mCRPC)
DrugsXtandi·Taxotere·Enzalutamide·Docetaxel
British Columbia Cancer Agency
Phase 2
100
Kelowna, Prince George, Surrey, Vancouver, Victoria, London, Toronto
2020-10-07
Active, closed
AbbVie
Phase 3
531
Surrey, Ottawa, Toronto, Montreal, Québec
2020-09-10
Recruiting
Salem Anaesthesia Pain Clinic
Observational
50
Surrey
2020-07-04
Recruiting
Salem Anaesthesia Pain Clinic
Observational
150
Surrey
2020-07-02
Active, closed
University of Sydney
Phase 3
1,100
Edmonton, Surrey, Brandon, Winnipeg, Saint John, St. John's, Kingston, London
2020-03-31
Recruiting
Salem Anaesthesia Pain Clinic
Observational
1,000
Surrey
2020-01-02
Active, closed
British Columbia Cancer Agency
Not applicable
330
Calgary, Kelowna, Prince George, Surrey, Vancouver, Victoria, London, Saint Catharines
2019-11-01
Recruiting
Population Health Research Institute
Phase 4
2,270
Calgary, Edmonton, Medicine Hat, Cranbrook, Surrey, Vancouver, Winnipeg, Moncton
2019-06-14
Recruiting
Rambam Health Care Campus
Phase 4
1,084
Calgary, Surrey, St. John's, Kingston, Montreal, Montreal, Quebec
2019-05-01
Active, closed
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
NCT03793179Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8
DrugsParaplatin·Pemetrexed·Keytruda·Carboplatin
National Cancer Institute (NCI)
Phase 3
600
Calgary, Edmonton, Surrey, Vancouver, Saint John, Kingston, Saint Catharines, Thunder Bay
2019-04-05
Active, closed
Sun Pharmaceutical Industries, Inc.
Phase 2/3
1,000
Calgary, Red Deer, Kelowna, Surrey, Winnipeg, Barrie, Etobicoke, Guelph
2019-04-04
Recruiting
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
NCT05685745Infant, Extremely Premature, Obstetric Labor, Premature, Premature Birth, Intensive Care, Neonatal
The University of Texas Health Science Center, Houston
Observational
5,000
Surrey, Toronto
2019-01-01
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Calgary, Edmonton, Kelowna, North Vancouver, Surrey, Vancouver, Halifax, Greater Sudbury
2018-12-07
Active, closed
Canadian Cancer Trials Group
Phase 3
2,138
Calgary, Edmonton, Abbotsford British Columbia, Kelowna, Prince George, Surrey, Vancouver, Victoria
2018-10-16
Recruiting
Salem Anaesthesia Pain Clinic
Observational
50
Surrey
2018-07-02
Active, closed
pharmaand GmbH
Phase 3
1,097
Calgary, Edmonton, Abbotsford British Columbia, Kelowna, Surrey, Winnipeg, Halifax, Hamilton
2018-05-14
Recruiting
Ottawa Heart Institute Research Corporation
Not applicable
282
Kelowna, Surrey, Vancouver, Halifax, London, Ottawa, Toronto, Montreal
2018-02-20
Recruiting
Ketamine Enhances Analgesia and Mood in Chronic Pain Patients
NCT05985811Mood Disorder; Opioid, Mood Insomnia
Salem Anaesthesia Pain Clinic
Observational
500
Surrey
2018-02-02
Recruiting
Pain Clinic Provides Public Health Safety
NCT06076512Social Functioning, Addiction, Substance, Safety Issues, Road Injury
Salem Anaesthesia Pain Clinic
Observational
1,000
Surrey
2018-02-02
Recruiting
Characteristics of Injury Claims by Chronic Pain Patients
NCT06104384Social Functioning, Chronic Pain, Injuries, Disabilities Multiple
Salem Anaesthesia Pain Clinic
Observational
1,000
Surrey
2018-01-02
Recruiting
Chronic Pelvic Pain in Females and Males
NCT06102733Pelvic Pain Syndrome, Sacroiliac Disorder, Piriformis Syndrome, Sacrococcygeal Disorder
Salem Anaesthesia Pain Clinic
Observational
1,000
Surrey
2018-01-02
Recruiting
Discrimination Harassment of Pain Staff Caused by Patient
NCT05945719Abuse, Sexual, Abuse, Workplace
Salem Anaesthesia Pain Clinic
Observational
1,000
Surrey
2017-11-01
Active, closed
Canadian Cancer Trials Group
Phase 2
301
Edmonton, Surrey, Vancouver, Fredericton, Moncton, Saint John, Cambridge, Greater Sudbury
2017-03-28
Active, closed
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
NCT02954874Breast Carcinoma In Situ, Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7
DrugsKeytruda·Pembrolizumab
National Cancer Institute (NCI)
Phase 3
1,195
Calgary, Edmonton, Surrey, Vancouver, Moncton, Saint John, St. John's, Hamilton
2017-01-18
Recruiting
Duration of Anti-PD-1 Therapy in Metastatic Melanoma
NCT02821013Unresectable/Metastatic Melanoma
Canadian Cancer Trials Group
Phase 3
614
Edmonton, Surrey, Vancouver, Victoria, Fredericton, Barrie, Greater Sudbury, Hamilton
2016-10-31
Active, closed
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Not applicable
90
Edmonton, Prince George, Surrey, Vancouver, Victoria, London, Toronto
2016-10
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
NCT02735707Respiratory Tract Diseases, Influenza (Pandemic), Influenza, Community Acquired Pneumonia
DrugsConvalescent plasma·Repagermanium·Ivermectin·Telmisartan
UMC Utrecht
Phase 3
20,000
Calgary, Edmonton, Surrey, Winnipeg, Fredericton, Brampton, Brantford, Hamilton
2016-04-11
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Calgary, Surrey, Vancouver, Victoria, London, Ottawa, Toronto, Gatineau
2015-11-19
Active, closed
University of Sydney
Phase 3
1,125
Calgary, Edmonton, Surrey, Vancouver, Winnipeg, Fredericton, Saint John, Halifax
2014-03
Active, closed
NOVOCART®3D for Treatment of Articular Cartilage of the Knee
NCT01957722Articular Cartilage of the Femoral Condyle Between 2-6cm2
DrugNOVOCART 3D
Aesculap Biologics, LLC
Phase 3
233
Edmonton, Surrey, Halifax, Hamilton, London
2013-12
Active, closed
AstraZeneca
Phase 3
510
Edmonton, Kelowna, Surrey, Halifax, Oshawa, Toronto, Montreal, Québec
2013-09-25
Active, closed
Radiation Therapy Oncology Group
Phase 3
2,590
Calgary, Edmonton, Kelowna, Surrey, St. John's, Halifax, London, Newmarket
2011-07
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
5,018
Abbotsford British Columbia, Kelowna, Surrey, Vancouver, Winnipeg, Saint John, St. John's, Barrie
2011-02-28
Recruiting
Caudal Analgesia & Anticoagulated Patient
NCT05946850Lumbar Pain Syndrome, Anticoagulants and Bleeding Disorders
Salem Anaesthesia Pain Clinic
Observational
100
Surrey
2008-01-02
Active, closed
Alliance for Clinical Trials in Oncology
Not applicable
—
Surrey, Moncton, Halifax, Hamilton, London, Ottawa, Toronto, Montreal
2007-10-12
Active, closed
Janssen Scientific Affairs, LLC
Observational
21,190
Calgary, Edmonton, Nanaimo, Surrey, Vancouver, Winnipeg, Fredericton, Moncton
2007-06-21
Active, closed
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
NCT00310180Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
10,273
Calgary, Kelowna, Penticton, Surrey, Vancouver, Victoria, Winnipeg, Moncton
2006-04-07
Rows per page Showing 1–138 of 138
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-canada/city/surrey

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,553 studies in total at the last sync on 10 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 138 of those studies with a site in Surrey.

How many clinical trials are recruiting in Surrey?

69 of the 138 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:20 UTC sync. A further 4 have not yet opened recruitment, 62 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Surrey), 138 studies
PhaseStudiesRecruitingShare
Phase 3732952.9%
Phase 221915.2%
Observational181513%
Not applicable1399.4%
Phase 4765.1%
Phase 2/3412.9%
Phase 1100.7%
Phase 1/2100.7%

Most active sponsors

Lead sponsors with the most studies (Surrey)
Lead sponsorStudiesRecruiting
Salem Anaesthesia Pain Clinic1212
AstraZeneca74
British Columbia Cancer Agency63
University of British Columbia64
AbbVie51
Canadian Cancer Trials Group52
Oruka Therapeutics, Inc.52
Eli Lilly and Company42
Janssen Research & Development, LLC40
Merck Sharp & Dohme LLC43
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.